912
Views
30
CrossRef citations to date
0
Altmetric
Original

Enhanced Oxygen Delivery to Primary Hepatocytes within a Hollow Fiber Bioreactor Facilitated via Hemoglobin-Based Oxygen Carriers

, , , &
Pages 585-606 | Published online: 11 Jul 2009

Figures & data

Figure 1 Schematic of the experimental hepatic hollow fiber bioreactor, along with a cross-sectional view of a single representative hollow fiber. Solid rectangles within the enlarged fiber represent the modeled space.

Figure 1 Schematic of the experimental hepatic hollow fiber bioreactor, along with a cross-sectional view of a single representative hollow fiber. Solid rectangles within the enlarged fiber represent the modeled space.

Table 1. Parameters of the hollow fiber bioreactor utilized in oxygen transport simulations

Figure 2 Comparison of experimentally measured oxygen consumption rates across the entire hollow fiber bioreactor along with values calculated by the oxygen transport model under identical conditions.

– Plain media,
– RBC supplemented media, and
– Oxygen transport simulations for both cases. Oxygen consumption rates were measured for the following sets of Q [mL/min] and inlet [mmHg]: A – 4.72/79, B – 8.35/85, C – 12.18/84, D – 4.72/77, E – 8.35/76, and F − 12.18/71.

Figure 2 Comparison of experimentally measured oxygen consumption rates across the entire hollow fiber bioreactor along with values calculated by the oxygen transport model under identical conditions. Display full size – Plain media, Display full size– RBC supplemented media, and Display full size– Oxygen transport simulations for both cases. Oxygen consumption rates were measured for the following sets of Q [mL/min] and inlet [mmHg]: A – 4.72/79, B – 8.35/85, C – 12.18/84, D – 4.72/77, E – 8.35/76, and F − 12.18/71.

Figure 3 Oxygen concentration profile predicted by the oxygen transport model at one of the experimental conditions; umax = 0.18 cm/s, , and no RBC supplementation – case A from Figure 2.

Figure 3 Oxygen concentration profile predicted by the oxygen transport model at one of the experimental conditions; umax = 0.18 cm/s, , and no RBC supplementation – case A from Figure 2.

Table 2. Clinically-relevant parameters of the hollow fiber bioreactor employed in oxygen transport simulations

Figure 4 Oxygen-hemoglobin equilibrium binding curves for bovine and human red blood cells predicted from the Adair constants presented in Tables and .

Figure 4 Oxygen-hemoglobin equilibrium binding curves for bovine and human red blood cells predicted from the Adair constants presented in Tables 1 and 2.

Figure 5 Hepatic zonation of the ECS in each of the defined oxygenation zones for the predicted bioreactor operating conditions at an inlet dissolved oxygen tension of 90 mmHg at several flow rates: G&J – 4.72 [mL/min], H&K – 8.35 [mL/min], and I&L – 12.18 [mL/min], with either plain media circulating (G, H, & I) or circulating RBC supplemented media at 10% of the human in vivo RBC concentration (J, K, & L).

Figure 5 Hepatic zonation of the ECS in each of the defined oxygenation zones for the predicted bioreactor operating conditions at an inlet dissolved oxygen tension of 90 mmHg at several flow rates: G&J – 4.72 [mL/min], H&K – 8.35 [mL/min], and I&L – 12.18 [mL/min], with either plain media circulating (G, H, & I) or circulating RBC supplemented media at 10% of the human in vivo RBC concentration (J, K, & L).

Figure 6 Oxygen concentration profiles predicted by the oxygen transport model at three predicted experimental conditions; umax = 0.465 cm/s and (a) 90mmHg with no RBC supplementation – case I from Figure 5, (b) 90mmHg with 10% supplementation of the human in vivo RBC concentration – case L from Figure 5, and (c) with 20% supplementation of the human in vivo RBC concentration.

Figure 6 Oxygen concentration profiles predicted by the oxygen transport model at three predicted experimental conditions; umax = 0.465 cm/s and (a) 90mmHg with no RBC supplementation – case I from Figure 5, (b) 90mmHg with 10% supplementation of the human in vivo RBC concentration – case L from Figure 5, and (c) with 20% supplementation of the human in vivo RBC concentration.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.